(Q36601830)

15 August 2017

1 reference

title

Vaccines for viral and parasitic diseases produced with baculovirus vectors (English)

1 reference

15 August 2017

0 references

Monique M van Oers

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Advances in Virus Research

15 August 2017

published in

1 reference

15 August 2017

volume

68

1 reference

15 August 2017

page(s)

193-253

1 reference

Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunological characterization of the VSV nucleocapsid (N) protein expressed by recombinant baculovirus in Spodoptera exigua larva: use in differential diagnosis between vaccinated and infected animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccinology: past achievements, present roadblocks and future promises

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunogenicity of hepatitis B surface antigen derived from the baculovirus expression vector system: a mouse potency study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The complete DNA sequence of Autographa californica nuclear polyhedrosis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of protective cytotoxic T cells with viral proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Update on the clinical development of candidate malaria vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Antigenic and immunogenic properties of a chimera of two immunodominant African swine fever virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Antigen-presenting cells 8015 (Provenge) in patients with androgen-dependent, biochemically relapsed prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Analysis of a recombinant dengue-2 virus-dengue-3 virus hybrid envelope protein expressed in a secretory baculovirus system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Theileria: intracellular protozoan parasites of wild and domestic ruminants transmitted by ixodid ticks

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Neutralizing antibody and protective immunity to SARS coronavirus infection of mice induced by a soluble recombinant polypeptide containing an N-terminal segment of the spike glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of cotton rats against human respiratory syncytial virus by vaccination with a novel chimeric FG glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Analysis of murine antibody responses to baculovirus-expressed human immunodeficiency virus type 1 envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Chimeric parvovirus B19 capsids for the presentation of foreign epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Large-scale production in Pichia pastoris of the recombinant vaccine Gavac against cattle tick

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Severe acute respiratory syndrome vaccine development: experiences of vaccination against avian infectious bronchitis coronavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Simplification of titer determination for recombinant baculovirus by green fluorescent protein marker.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Modulation of translational efficiency by contextual nucleotides flanking a baculovirus initiator AUG codon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

High-level expression of canine parvovirus VP2 using Bombyx mori nucleopolyhedrovirus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Production of mink enteritis parvovirus empty capsids by expression in a baculovirus vector system: a recombinant vaccine for mink enteritis parvovirus in mink.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Second-generation vaccines against leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Virus-like particles as a rotavirus subunit vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Evaluation of rubella virus E2 and C proteins in protection against rubella virus in a mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

A structured dynamic model for the baculovirus infection process in insect-cell reactor configurations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Molecular analysis of astacin-like metalloproteases of Ostertagia ostertagi

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

An aspartyl protease inhibitor of Ostertagia ostertagi: molecular cloning, analysis of stage and tissue specific expression and vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Classical swine fever (CSF) marker vaccine. Trial II. Challenge study in pregnant sows.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant neuraminidase vaccine protects against lethal influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Genetically engineered vaccines: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of HIV‐1 envelope (gp120)‐specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell‐derived gp120 is enhanced by enzymatic removal of N‐linked glycans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Is there an advantage to including the nucleoprotein in a rabies glycoprotein subunit vaccine?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

A prototype recombinant vaccine against respiratory syncytial virus and parainfluenza virus type 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization of monkeys with baculovirus-dengue type-4 recombinants containing envelope and nonstructural proteins: evidence of priming and partial protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus vectors elicit antigen-specific immune responses in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Dengue type-2 virus envelope protein made using recombinant baculovirus protects mice against virus challenge.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination against hepatitis delta virus infection: studies in the woodchuck (Marmota monax) model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Rabies and rabies research: past, present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Oral vaccination of racoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Murine HIV-1 p24 specific T lymphocyte activation by different antigen presenting cells: B lymphocytes from immunized mice present core protein to T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant poxviruses as mucosal vaccine vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunoselection of recombinant baculoviruses expressing high levels of biologically active herpes simplex virus type 1 glycoprotein D.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination with a cocktail of seven recombinantly expressed HSV-1 glycoproteins protects against ocular HSV-1 challenge more efficiently than vaccination with any individual glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination with different HSV-1 glycoproteins induces different patterns of ocular cytokine responses following HSV-1 challenge of vaccinated mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Antibody-dependent enhancement of HSV-1 infection by anti-gK sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Trypanosoma cruzi-induced molecular mimicry and Chagas' disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Characterization of tick-borne encephalitis virus-specific human T lymphocyte responses by stimulation with structural TBEV proteins expressed in a recombinant baculovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Lymphocyte proliferative responses following immunization with human immunodeficiency virus recombinant GP160. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Augmentation of human immunodeficiency virus type 1 neutralizing antibody by priming with gp160 recombinant vaccinia and boosting with rgp160 in vaccinia-naive adults. The NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of swine against foot-and-mouth disease with viral capsid proteins expressed in heterologous systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The bovine parainfluenza virus type-3 (BPIV-3) hemagglutinin/neuraminidase glycoprotein expressed in baculovirus protects calves against experimental BPIV-3 challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of cotton rats by immunization with the human parainfluenza virus type 3 fusion (F) glycoprotein expressed on the surface of insect cells infected with a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Design and production of recombinant subunit vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Molecular characterization and baculovirus expression of the glycoprotein B of a seal herpesvirus (phocid herpesvirus-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The role of the AcMNPV 25K gene, "FP25," in baculovirus polh and p10 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Liquefaction of Autographa californica nucleopolyhedrovirus-infected insects is dependent on the integrity of virus-encoded chitinase and cathepsin genes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Overview of marker vaccine and differential diagnostic test technology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Antigenicity and vaccine potential of Marburg virus glycoprotein expressed by baculovirus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunomodulation by filarial nematodes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccine efficacy of a cell lysate with recombinant baculovirus-expressed feline infectious peritonitis (FIP) virus nucleocapsid protein against progression of FIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

What is the function of MSP-I on the malaria merozoite?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Autographa californica M nucleopolyhedrovirus ProV-CATH is activated during infected cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Development of a novel subunit vaccine that protects cotton rats against both human respiratory syncytial virus and human parainfluenza virus type 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection against Schistosoma mansoni infection with a recombinant baculovirus-expressed subunit of calpain

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

From gene to protein: a review of new and enabling technologies for multi-parallel protein expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization with recombinant surface antigens p26 with Freund's adjuvants against Babesia rodhaini infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Insect cell culture for industrial production of recombinant proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Characterization of pseudorabies virus neutralization antigen glycoprotein gIII produced in insect cells by a baculovirus expression vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Developing baculovirus-insect cell expression systems for humanized recombinant glycoprotein production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus expression vectors that incorporate the foreign protein into viral occlusion bodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

A nasal Proteosome influenza vaccine containing baculovirus-derived hemagglutinin induces protective mucosal and systemic immunity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Fusion to green fluorescent protein improves expression levels of Theileria parva sporozoite surface antigen p67 in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus surface display of Theileria parva p67 antigen preserves the conformation of sporozoite-neutralizing epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Development of a chitinase and v-cathepsin negative bacmid for improved integrity of secreted recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Improved immunogenicity of novel baculovirus-derived Theileria parva p67 subunit antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Novel baculovirus-derived p67 subunit vaccines efficacious against East Coast fever in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Partial control of hepatitis delta virus superinfection by immunisation of woodchucks (Marmota monax) with hepatitis delta antigen expressed by a recombinant vaccinia or baculovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Improvement of the production of GFPuv-beta1,3-N-acetylglucosaminyltransferase 2 fusion protein using a molecular chaperone-assisted insect-cell-based expression system.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Pathogenesis of and immunity to avian influenza A H5 viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Human immunodeficiency virus (HIV-1) gp160-specific lymphocyte proliferative responses of mononuclear leukocytes from HIV-1 recombinant gp160 vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Studies of high doses of a human immunodeficiency virus type 1 recombinant glycoprotein 160 candidate vaccine in HIV type 1-seronegative humans. The AIDS Vaccine Clinical Trials Network.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization of egg-allergic individuals with egg- or chicken-derived vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of mice with recombinant influenza virus neuraminidase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Linearization of baculovirus DNA enhances the recovery of recombinant virus expression vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunogenic and protective properties of chicken anaemia virus proteins expressed by baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Detection and analysis of Autographa californica nuclear polyhedrosis virus mutants with defective interfering properties

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant baculoviruses as mammalian cell gene-delivery vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of glycoprotein D of herpes simplex virus type 1 in a recombinant baculovirus: protective responses and T cell recognition of the recombinant-infected cell extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Enzyme-linked immunosorbent assay using a virus type-specific peptide based on a subdomain of envelope protein E(rns) for serologic diagnosis of pestivirus infections in swine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of muscovy duck parvovirus capsid proteins (VP2 and VP3) in a baculovirus expression system and demonstration of immunity induced by the recombinant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Feasibility of baculovirus-expressed recombinant 10-kDa antigen in the serodiagnosis of Taenia solium neurocysticercosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Reiterated DNA fragments in defective genomes of Autographa californica nuclear polyhedrosis virus are competent for AcMNPV-dependent DNA replication

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Comparison of soluble and secreted forms of human parainfluenza virus type 3 glycoproteins expressed from mammalian and insect cells as subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Characterization, cloning, and expression of two diagnostic antigens for Taenia solium tapeworm infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of cynomolgus monkeys against HEV infection by oral administration of recombinant hepatitis E virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Cytokines as adjuvants for ruminant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Function, oligomerization and N-linked glycosylation of the Helicoverpa armigera single nucleopolyhedrovirus envelope fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of the outer capsid protein vp5 of two bluetongue viruses, and synthesis of chimeric double-Shelled virus-like particles using combinations of recombinant baculoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Autoreactivity in HIV-infected individuals does not increase during vaccination with envelope rgp160.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression and properties of feline herpesvirus type 1 gD (hemagglutinin) by a recombinant baculovirus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Antibodies to the major linear neutralizing domains of cytomegalovirus glycoprotein B among natural seropositives and CMV subunit vaccine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Development of a baculovirus vector that facilitates the generation of p10-based recombinants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The roles of the glycosylphosphatidylinositol anchor on the production and immunogenicity of recombinant ookinete surface antigen Pbs21 of Plasmodium berghei when prepared in a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Production of porcine parvovirus empty capsids with high immunogenic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of anti-malarial transmission blocking immunity with a recombinant ookinete surface antigen of Plasmodium berghei produced in silkworm larvae using the baculovirus expression vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immune responses elicited by recombinant vaccinia-human immunodeficiency virus (HIV) envelope and HIV envelope protein: analysis of the durability of responses and effect of repeated boosting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Comparison of the protective efficacy of DNA and baculovirus-derived protein vaccines for EBOLA virus in guinea pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Serum antibodies to HIV-1 in recombinant vaccinia virus recipients boosted with purified recombinant gp160. NIAID AIDS Vaccine Clinical Trials Network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Neutralizing antibodies to African swine fever virus proteins p30, p54, and p72 are not sufficient for antibody-mediated protection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant virus-like particles of a norovirus (genogroup II strain) administered intranasally and orally with mucosal adjuvants LT and LT(R192G) in BALB/c mice induce specific humoral and cellular Th1/Th2-like immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination with a heterologous respiratory syncytial virus chimeric FG glycoprotein demonstrates significant subgroup cross-reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Conserved molecular systems of the Baculoviridae

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of bovine herpesvirus 1 glycoprotein gIII by a recombinant baculovirus in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Control of Theileria sergenti infection by vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immune responses and protective efficacy of recombinant baculovirus-expressed glycoproteins of equine herpesvirus 1 (EHV-1) gB, gC and gD alone or in combinations in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Influenza: old and new threats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The glycosylation pattern of baculovirus expressed envelope protein E2 affects its ability to prevent infection with bovine viral diarrhoea virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Allergic reactions to measles-mumps-rubella vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Genetically engineered multi-component virus-like particles as veterinary vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Time reduction and process optimization of the baculovirus expression system for more efficient recombinant protein production in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Autographa californica baculoviruses with large genomic deletions are rapidly generated in infected insect cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Pivotal role of the non-hr origin of DNA replication in the genesis of defective interfering baculoviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Cell line-specific accumulation of the baculovirus non-hr origin of DNA replication in infected insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect-cell bioreactors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Stabilized baculovirus vector expressing a heterologous gene and GP64 from a single bicistronic transcript

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Failure of viral protein 3 of infectious bursal disease virus produced in prokaryotic and eukaryotic expression systems to protect chickens against the disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus expression of proteins of porcine reproductive and respiratory syndrome virus strain Olot/91. Involvement of ORF3 and ORF5 proteins in protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Generation of recombinant influenza virus using baculovirus delivery vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The use of baculovirus vectors for the production of membrane proteins in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunogenic and protective properties of rabies virus glycoprotein expressed by baculovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of sterilizing immunity against West Nile Virus (WNV), by immunization with WNV-like particles produced in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunoreactivity and protective effects in mice of a recombinant dengue 2 Tonga virus NS1 protein produced in a baculovirus expression system

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of the fusion glycoprotein of human parainfluenza type 3 virus in insect cells by a recombinant baculovirus and analysis of its immunogenic property

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Fasciola hepatica procathepsin L3 protein expressed by a baculovirus recombinant can partly protect rats against fasciolosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Synthesis of immunogenic hepatitis A virus particles by recombinant baculoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Genetically engineered particulate virus-like structures and their use as vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Functional and immunological properties of the baculovirus-expressed hemagglutinin of African swine fever virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Update on adenovirus and its vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of YAV proteins and vaccination against viral ascites among cultured juvenile yellowtail

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Deletion of the Autographa californica nucleopolyhedrovirus chitinase KDEL motif and in vitro and in vivo analysis of the modified virus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination against canine babesiosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Mechanisms of vaccine adjuvant activity: initiation and regulation of immune responses by vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection against congenital cytomegalovirus infection and disease in guinea pigs, conferred by a purified recombinant glycoprotein B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus expression of the M genome segment of Rift Valley fever virus and examination of antigenic and immunogenic properties of the expressed proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Active immunity and T-cell populations in pigs intraperitoneally inoculated with baculovirus-expressed transmissible gastroenteritis virus structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immune responses of lambs to the fusion (F) glycoprotein of bovine respiratory syncytial virus expressed on insect cells infected with a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immune responses in goats to recombinant hemagglutinin-neuraminidase glycoprotein of Peste des petits ruminants virus: identification of a T cell determinant

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Recombinant hemagglutinin protein of rinderpest virus expressed in insect cells induces cytotoxic T-cell responses in cattle

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Production of Human Beta Interferon in Insect Cells Infected with a Baculovirus Expression Vector

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of protective immunity in chickens vaccinated with infectious bronchitis virus S1 glycoprotein expressed by a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The production of a truncated form of baculovirus expressed EHV-1 glycoprotein C and its role in protection of C3H (H-2Kk) mice against virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

High level expression of equine herpesvirus 1 glycoproteins D and H and their role in protection against virus challenge in the C3H (H-2Kk) murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Plant production systems for vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Production and in vivo testing of a recombinant bovine IL-12 as an adjuvant for Salmonella typhimurium vaccination in calves.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunological properties of FMDV-gP64 fusion proteins expressed on SF9 cell and baculovirus surfaces.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

In vitro and in vivo gene delivery by recombinant baculoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Molecular chaperones stimulate the functional expression of the cocaine-sensitive serotonin transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Reduced oviposition of Boophilus microplus feeding on sheep vaccinated with vitellin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Comparing N-glycan processing in mammalian cell lines to native and engineered lepidopteran insect cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Structure and expression in baculovirus of the Mokola virus glycoprotein: an efficient recombinant vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Potential viral vectors for the stimulation of mucosal antibody responses against enteric viral antigens in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Synthesis and assembly of hepatitis B virus surface antigen particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Development of recombinant vaccines against bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The baculovirus 10-kDa protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Secretory pathway limits the enhanced expression of classical swine fever virus E2 glycoprotein in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Diva vaccines that reduce virus transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of biologically active and antigenically authentic parainfluenza type 3 virus hemagglutinin-neuraminidase glycoprotein by a recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Induction of protective immunity against Dengue virus type 2: comparison of candidate live attenuated and recombinant vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunity to St. Louis encephalitis virus by sequential immunization with recombinant vaccinia and baculovirus derived PrM/E proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Expression of cauliflower mosaic virus gene I using a baculovirus vector based upon the p10 gene and a novel selection method

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Cloning of biologically active genomes from a Helicoverpa armigera single-nucleocapsid nucleopolyhedrovirus isolate by using a bacterial artificial chromosome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Self-assembly of the infectious bursal disease virus capsid protein, rVP2, expressed in insect cells and purification of immunogenic chimeric rVP2H particles by immobilized metal-ion affinity chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Vaccination of cotton rats with a chimeric FG glycoprotein of human respiratory syncytial virus induces minimal pulmonary pathology on challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immune response to baculovirus expressed protein fragment amino acids 190-289 of respiratory syncytial virus (RSV) fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

A Baculovirus Dual Expression Vector Derived from the Autographa Californica Nuclear Polyhedrosis Virus Polyhedrin and p10 Promoters: Co-expression of Two Influenza Virus Genes in Insect Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Characteristics of equine herpesvirus 1 glycoproteins expressed in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Commercialisation of a recombinant vaccine against Boophilus microplus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Characterization of pseudorabies virus glycoprotein gII expressed by recombinant baculovirus

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Characterization of canine herpesvirus glycoprotein C expressed by a recombinant baculovirus in insect cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Production and characterization of simian--human immunodeficiency virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Intranasal immunization with SIV virus-like particles (VLPs) elicits systemic and mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Viral gene therapy strategies: from basic science to clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Calreticulin promotes folding/dimerization of human lipoprotein lipase expressed in insect cells (sf21).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Babesia divergens, a bovine blood parasite of veterinary and zoonotic importance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

The GP64 envelope fusion protein is an essential baculovirus protein required for cell-to-cell transmission of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Protection from La Crosse virus encephalitis with recombinant glycoproteins: role of neutralizing anti-G1 antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0065-3527%2806%2968006-8

7 January 2021

Immunization of mice with a TolA-like surface protein of Trypanosoma cruzi generates CD4(+) T-cell-dependent parasiticidal activity.

1 reference

12 December 2020

Nature and duration of protective immunity to bluetongue virus infection

1 reference

12 December 2020

Technology evaluation: HIVAC-1e.

1 reference

12 December 2020

Recombinant vaccine for canine parvovirus in dogs

1 reference

12 December 2020

Immunological responses of mice and cattle to baculovirus-expressed F and H proteins of rinderpest virus: lack of protection in the presence of neutralizing antibody.

1 reference

12 December 2020

Immunotherapy of SV40 induced tumours in mice: a model for vaccine development

1 reference

12 December 2020

Preventing proteolytic artifacts in the baculovirus expression system

1 reference

12 December 2020

Adventures with poxviruses of vertebrates

1 reference

12 December 2020

Glycoprotein E1 of hog cholera virus expressed in insect cells protects swine from hog cholera

1 reference

12 December 2020

Baculovirus expression vector system for production of viral vaccines.

1 reference

12 December 2020

A Phase I, randomized controlled clinical trial to study the reactogenicity and immunogenicity of a new split influenza vaccine derived from a non-tumorigenic cell line

1 reference

12 December 2020

Recombinant Norwalk virus-like particles as an oral vaccine.

1 reference

12 December 2020

Development of a subunit vaccine for infectious pancreatic necrosis virus using a baculovirus insect/larvae system

1 reference

12 December 2020

B-cell activation and differentiation by HIV-1 antigens among volunteers vaccinated with VaxSyn HIV-1.

1 reference

12 December 2020

A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees.

1 reference

12 December 2020

A method for producing recombinant baculovirus expression vectors at high frequency.

1 reference

12 December 2020

Oral immunization with recombinant Norwalk virus-like particles induces a systemic and mucosal immune response in mice

1 reference

12 December 2020

Protection of mice against lethal Japanese encephalitis with a recombinant baculovirus vaccine

1 reference

12 December 2020

Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants.

1 reference

12 December 2020

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications

1 reference

12 December 2020

Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli.

1 reference

12 December 2020

Circulating vaccine-derived polioviruses: current state of knowledge

1 reference

12 December 2020

Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza

1 reference

12 December 2020

Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties

1 reference

12 December 2020

New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.

1 reference

12 December 2020

Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.

1 reference

12 December 2020

Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.

1 reference

12 December 2020

Is there a future for vaccines against gastrointestinal helminths?

1 reference

12 December 2020

Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice

1 reference

12 December 2020

Influvac: a safe Madin Darby Canine Kidney (MDCK) cell culture-based influenza vaccine

1 reference

12 December 2020

Cell-based protein vaccines for influenza

1 reference

12 December 2020

Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins

1 reference

12 December 2020

Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination.

1 reference

12 December 2020

Expression of the Newcastle disease virus (NDV) fusion glycoprotein and vaccination against NDV challenge with a recombinant baculovirus

1 reference

12 December 2020

Technology evaluation: APC-8015, Dendreon.

1 reference

12 December 2020

Characterization of an insect cell-derived Theileria parva sporozoite vaccine antigen and immunogenicity in cattle

1 reference

12 December 2020

Recombinant subunit vaccines: potentials and constraints.

1 reference

12 December 2020

Insect cell-derived VP2 of infectious bursal disease virus confers protection against the disease in chickens

1 reference

12 December 2020

Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis

1 reference

12 December 2020

HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.

1 reference

12 December 2020

Localization of a baculovirus-induced chitinase in the insect cell endoplasmic reticulum.

1 reference

12 December 2020

10.1016/S0065-3527(06)68006-8

Identifiers

DOI

1 reference

15 August 2017

1 reference